These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 20205614

  • 1. Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?
    Grauslund J, Rasmussen LM, Green A, Sjølie AK.
    Scand J Clin Lab Invest; 2010 Apr 19; 70(3):188-93. PubMed ID: 20205614
    [Abstract] [Full Text] [Related]

  • 2. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J.
    Acta Ophthalmol; 2011 Feb 19; 89 Thesis 1():1-19. PubMed ID: 21443578
    [Abstract] [Full Text] [Related]

  • 3. N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.
    Grauslund J, Nybo M, Green A, Sjølie AK.
    Scand J Clin Lab Invest; 2010 Oct 19; 70(6):392-8. PubMed ID: 20575653
    [Abstract] [Full Text] [Related]

  • 4. Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus.
    Tavintharan S, Pek LT, Liu JJ, Ng XW, Yeoh LY, Su Chi L, Chee Fang S.
    Diab Vasc Dis Res; 2014 Sep 19; 11(5):359-62. PubMed ID: 25005034
    [Abstract] [Full Text] [Related]

  • 5. Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients.
    Nybo M, Poulsen MK, Grauslund J, Henriksen JE, Rasmussen LM.
    Diabet Med; 2010 Mar 19; 27(3):289-94. PubMed ID: 20536491
    [Abstract] [Full Text] [Related]

  • 6. Long-term mortality and retinopathy in type 1 diabetes.
    Grauslund J.
    Acta Ophthalmol; 2010 May 19; 88 Thesis1():1-14. PubMed ID: 20500731
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association between microfibrillar-associated protein 4 (MFAP4) and micro- and macrovascular complications in long-term type 1 diabetes mellitus.
    Blindbæk SL, Schlosser A, Green A, Holmskov U, Sorensen GL, Grauslund J.
    Acta Diabetol; 2017 Apr 19; 54(4):367-372. PubMed ID: 28039584
    [Abstract] [Full Text] [Related]

  • 10. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.
    Elsamahy MH, Elhenawy YI, Nawar MM.
    J Diabetes Complications; 2015 Apr 19; 29(4):563-7. PubMed ID: 25744546
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes.
    Blázquez-Medela AM, García-Ortiz L, Gómez-Marcos MA, Recio-Rodriguez JI, Sánchez-Rodríguez A, López-Novoa JM, Martínez-Salgado C.
    Eur J Clin Invest; 2012 May 19; 42(5):548-56. PubMed ID: 22050177
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients.
    Xiang GD, Sun HL, Zhao LS.
    Diabetes Res Clin Pract; 2007 May 19; 76(2):199-206. PubMed ID: 17023086
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus.
    Guzel S, Seven A, Kocaoglu A, Ilk B, Guzel EC, Saracoglu GV, Celebi A.
    Diab Vasc Dis Res; 2013 Jan 19; 10(1):25-31. PubMed ID: 22496403
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.